Literature DB >> 28073429

Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, With Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study).

Mathew S Maurer1, William J H Koh2, Traci M Bartz2, Sirish Vullaganti3, Eddy Barasch4, Julius M Gardin5, John S Gottdiener6, Bruce M Psaty7, Jorge R Kizer8.   

Abstract

We evaluated the association between 2-dimensional (2D) echocardiography (echo)-determined myocardial contraction fraction (MCF) and adverse cardiovascular outcomes including incident heart failure (HF), atherosclerotic cardiovascular disease (ASCVD), and mortality. The MCF, the ratio of left ventricular (LV) stroke volume (SV) to myocardial volume (MV), is a volumetric measure of myocardial shortening that can distinguish pathologic from physiological hypertrophy. Using 2D echo-guided M-mode data from the Cardiovascular Health Study, we calculated MCF in subjects with LV ejection fraction (EF) ≥55% and used Cox models to evaluate its association with incident HF, ASCVD, and all-cause mortality after adjusting for clinical and echo parameters. We assessed whether log2(SV) and log2(MV) were consistent with the expected 1:-1 ratio used in the definition of MCF. Among 2,147 participants (age 72 ± 5 years), average MCF was 59 ± 13%. After controlling for clinical and echo variables, each 10% absolute increment in MCF was associated with lower risk of HF (hazard ratio [HR] 0.88; 95% confidence interval [CI] 0.82, 0.94), ASCVD (HR 0.90; 95% CI 0.85, 0.95), and death (HR 0.93; 95% CI 0.89, 0.97). Moreover, the MCF was still significantly associated with ASCVD and mortality, but not HF, after adjustment for percent-predicted LV mass. Significant departure from the 1:-1 ratio was not observed for ASCVD or death, but did occur for HF, driven by a stronger association for MV than SV. In conclusion, among older adults without CVD or low LV ejection fraction, 2D echo-guided M-mode-derived MCF was independently associated with lower risk of adverse cardiovascular outcomes, but this ratiometric index may not capture the full relation that is apparent when its components are modeled separately in the case of HF.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28073429      PMCID: PMC5328842          DOI: 10.1016/j.amjcard.2016.11.048

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging.

Authors:  G A Stewart; J Foster; M Cowan; E Rooney; T McDonagh; H J Dargie; R S Rodger; A G Jardine
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

2.  Noncompressibility of myocardium during systole with freehand three-dimensional echocardiography.

Authors:  Donald L King; Lyna El-Khoury Coffin; Mathew S Maurer
Journal:  J Am Soc Echocardiogr       Date:  2002-12       Impact factor: 5.251

3.  Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure.

Authors:  Mathew S Maurer; Jonathan D Sackner-Bernstein; Lyna El-Khoury Rumbarger; Madeline Yushak; Donald L King; Daniel Burkhoff
Journal:  Circ Heart Fail       Date:  2009-04-14       Impact factor: 8.790

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.

Authors:  D W Kitzman; J M Gardin; J S Gottdiener; A Arnold; R Boineau; G Aurigemma; E K Marino; M Lyles; M Cushman; P L Enright
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

6.  Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography.

Authors:  G de Simone; R B Devereux; A Ganau; R T Hahn; P S Saba; G F Mureddu; M J Roman; B V Howard
Journal:  Am J Cardiol       Date:  1996-10-01       Impact factor: 2.778

7.  Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.

Authors:  E J Erlandsen; E Randers; J H Kristensen
Journal:  Scand J Clin Lab Invest       Date:  1999-02       Impact factor: 1.713

8.  Measures of Body Size and Composition and Risk of Incident Atrial Fibrillation in Older People: The Cardiovascular Health Study.

Authors:  Maria G Karas; Laura M Yee; Mary L Biggs; Luc Djoussé; Kenneth J Mukamal; Joachim H Ix; Susan J Zieman; David S Siscovick; John S Gottdiener; Michael A Rosenberg; Richard A Kronmal; Susan R Heckbert; Jorge R Kizer
Journal:  Am J Epidemiol       Date:  2016-05-05       Impact factor: 4.897

9.  Relationship of contractile state to ejection performance in patients with chronic aortic valve disease.

Authors:  T Wisenbaugh; D Booth; A DeMaria; S Nissen; J Waters
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

10.  Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study.

Authors:  J M Gardin; N D Wong; W Bommer; H S Klopfenstein; V E Smith; B Tabatznik; D Siscovick; S Lobodzinski; H Anton-Culver; T A Manolio
Journal:  J Am Soc Echocardiogr       Date:  1992 Jan-Feb       Impact factor: 5.251

View more
  5 in total

1.  Association between reduced myocardial contraction fraction and cardiovascular disease outcomes: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Marwah Abdalla; Elvis A Akwo; David A Bluemke; João A C Lima; Daichi Shimbo; Mathew S Maurer; Alain G Bertoni
Journal:  Int J Cardiol       Date:  2019-07-11       Impact factor: 4.164

2.  Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure-Volume Analysis.

Authors:  Jaya Batra; Hannah Rosenblum; Ersilia M Defilippis; Jan M Griffin; Sunil E Saith; Danilo Gamino; Sergio Teruya; Jeffeny De Los Santos; Stephen Helmke; Daniel Burkhoff; Mathew S Maurer
Journal:  J Card Fail       Date:  2020-08-20       Impact factor: 5.712

3.  Circulating extracellular RNAs, myocardial remodeling, and heart failure in patients with acute coronary syndrome.

Authors:  Khanh-Van Tran; Kahraman Tanriverdi; Gerard P Aurigemma; Darleen Lessard; Mayank Sardana; Matthew Parker; Amir Shaikh; Matthew Gottbrecht; Zachary Milstone; Selim Tanriverdi; Olga Vitseva; John F Keaney; Catarina I Kiefe; David D McManus; Jane E Freedman
Journal:  J Clin Transl Res       Date:  2019-06-08

4.  The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2.

Authors:  Yiqing Yang; Muisha B Mbikyo; Junzhe Zhang; Yuan Zhang; Naijin Zhang; Zhao Li
Journal:  Cell Death Discov       Date:  2022-04-05

5.  Prognostic impact of myocardial contraction fraction in patients undergoing transcatheter aortic valve replacement for aortic stenosis.

Authors:  Francisco J Romeo; Ignacio M Seropian; Sameer Arora; John P Vavalle; Mariano Falconi; Pablo Oberti; Vadim Kotowicz; Carla R Agatiello; Daniel H Berrocal
Journal:  Cardiovasc Diagn Ther       Date:  2020-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.